The final chapter of the ALS lithium saga

The Lancet Neurology

Volumn 12, Issue 4, 2013, Pages 324-325

  Chiò, Adriano ^a   Mora, Gabriele ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ABSENCE OF SIDE EFFECTS; AMYOTROPHIC LATERAL SCLEROSIS; BIPOLAR DISORDER; CLUSTER HEADACHE; DISEASE COURSE; DRUG EFFICACY; DRUG SCREENING; HUMAN; LETTER; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE;

AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE;

EID: 84875264179     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70040-1     Document Type: Letter

References (10)

1. Ludolph AC, Bendotti C, Blaugrund E, et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler 2010, 11:38-45.
2. Beghi E, Chiò A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 2011, 12:1-10.
3. Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2008, 105:2052-2057.
4. Chiu CT, Chuang DM Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 2010, 128:281-304.
5. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2013, UKMND-LiCALS Study Group, published online Feb 27. http://dx.doi.org/10.1016/S1474-4422(13)70037-1.
6. Aggarwal SP, Zinman L, Simpson E, et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:481-488.
7. Chio A, Borghero G, Calvo A, et al. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology 2010, 75:619-625.
8. Miller RG, Moore DH, Forshew DA, et al. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology 2011, 77:973-979.
9. Wicks P, Vaughan TE, Massagli MP, Heywood J Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotechnol 2011, 29:411-414.
10. Verstraete E, Veldink JH, Huisman MH, et al. Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial. J Neurol Neurosurg Psychiatry 2012, 83:557-564.